AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.
The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.
9 小时
ABP Live on MSNGBS Syndrome: Know Symptoms, Causes, And Everything About This Neurological DisorderGuillain-Barré Syndrome (GBS) is a rare autoimmune disorder that causes muscle weakness, numbness, and even paralysis.
After multiple cases of Guillain-Barré Syndrome were reported in Pune, Mumbai has now recorded its first case—a 64-year-old ...
AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.
A new, comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite ...
8 小时on MSN
The bill would require that a person must be 18 to give medical consent unless they are married, divorced, pregnant, ...
Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.
Researchers have used artificial intelligence to identify 25 new protein compounds that can kill bacteria and fungi, ...
The flu can also cause a general feeling of fatigue or malaise, Ray says, as well as gastrointestinal issues like diarrhea ...
Early detection and public health interventions are critical in improving sepsis survival rates and limiting its long-term ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果